Cyril Allouche

Principal Financial Officer, Revance Therapeutics, Inc.

Companies

Revance Therapeutics, Inc.Principal Financial Officer Jun 22, 2018 to Mar 19, 2019¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARRevance Therapeutics, Inc., Principal Financial Officer